Pegcetacoplan in the Trials and the Real-World

David A. Eichenbaum, MD

Show Description +

Dr. Eichenbaum provides an update on pegcetacoplan (Syfovre, Apellis) for the treatment of geographic atrophy, both from the clinical trial data and real-world experiences.

Posted: 7/25/2024

Keywords:

retina-meeting-recap

•

Pegcetacoplan

•

Syfovre

•

Apellis

•

Clinical Trials

•

Geographic Atrophy (GA)

Up Next

Name: Pegcetacoplan in the Trials and the Real-World
Uploaded: 2024-07-25T20:12:21+00:00
Description: Dr. Eichenbaum provides an update on pegcetacoplan (Syfovre, Apellis) for the treatment of geographic atrophy, both from the clinical trial data and real-world experiences.

An Update on AVD-104 for the Treatment of GA

Rishi P. Singh, MD

Gene Therapy for Wet AMD Shows Promise

Charles C. Wykoff, MD, PhD, FASRS, FACS

Using Retinal Imaging to Identify Alzheimer Biomarkers

Sruthi Arepalli, MD

The Effect of Vitrectomy on AMD Progression

Chase Ludwig, MD

Using AI to Track GA Treatment Response

Ursula M. Schmidt-Erfurth, MD

More on Faricimab for DME: Efficacy and Safety

Chirag Jhaveri, MD

96-Week Safety Data Revealed for 8 mg Aflibercept

Christina Y. Weng, MD, MBA

Exploring DME Outcomes Based on Baseline Vision

Diana V. Do, MD

The PDS: Technical Changes and Clinical Experiences

Dante J. Pieramici, MD

Back to All Videos

Pegcetacoplan in the Trials and the Real-World

David A. Eichenbaum, MD

Dr. Eichenbaum provides an update on pegcetacoplan (Syfovre, Apellis) for the treatment of geographic atrophy, both from the clinical trial data and real-world experiences.

Posted: 7/25/2024

Keywords:

retina-meeting-recap

•

Pegcetacoplan

•

Syfovre

•

Apellis

•

Clinical Trials

•

Geographic Atrophy (GA)

Please log in to leave a comment.

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

Pegcetacoplan in the Trials and the Real-World

Up Next

Pegcetacoplan in the Trials and the Real-World

More From ASRS: 2024 Coverage